Chronic active hepatitis in alcoholic patients

Chronic Hepatitis/Chronic Active Hepatitis in Dogs

YMDD and FLLAQ Mutations in Chronic Hepatitis B Patients

Abstract Background and Objective: Lamivudine is the first orally available drug approved for treatment of chronic hepatitis B. Mutations at the YMDD and FLLAQ motifs in the domains of HBV polymerase gene contribute resistance to lamivudine. This study was aimed to determine the rate of YMDD and FLLAQ mutants in hepatitis B patients in Golestan Province, Iran. Material and methods: In this cros...

Involvement in Chronic Active Hepatitis

Rabbit liver plasma membranes were isolated and purified by using an aqueous twophase polymer system. Examination of these preparations with respect to electronmicroscopical appearance, distribution of marker enzymes and gross biochemical composition revealed them to be free from contamination by intracellular components. Sera from ten patients with chronic active hepatitis, four with and six w...

Chronic Active Hepatitis

Our previous observations of highly significant increases in high titre antibodies to measles and rubella in patients with chronic active hepatitis have been extended and it has been shown that these reactions do not occur in other forms of liver disease. Significant increases in antibody titres to cytomegalovirus have also been found in patients with chronic active hepatitis (p<0001) and alcoh...

Immunological Studies in Patients with HBsAg-positive Chronic Active Hepatitis